Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Epratuzumab: Phase II data

In a Phase II trial in 11 patients, 4

Read the full 95 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE